132 related articles for article (PubMed ID: 18842170)
1. Sublingual immunotherapy provides an early increase of interferon-gamma production.
Ciprandi G; Fenoglio D; Di Gioacchino M; Ferrera A; Ferrera F; Sormani MP; Marseglia GL
J Biol Regul Homeost Agents; 2008; 22(3):169-73. PubMed ID: 18842170
[TBL] [Abstract][Full Text] [Related]
2. Carry-over effect on IFN-gamma production induced by allergen-specific immunotherapy.
Ciprandi G; Sormani MP; Filaci G; Fenoglio D
Int Immunopharmacol; 2008 Dec; 8(12):1622-5. PubMed ID: 18691675
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
4. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-4 as a marker of immunological response to sublingual immunotherapy.
Ciprandi G; De Amici M; Murdaca G; Colombo BM; Quaglini S; Marseglia G; Di Gioacchino M
J Biol Regul Homeost Agents; 2008; 22(2):117-23. PubMed ID: 18597704
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports.
Ciprandi G; Cirillo I; Fenoglio D; Marseglia G; Tosca MA
Int Immunopharmacol; 2006 Aug; 6(8):1370-3. PubMed ID: 16782551
[TBL] [Abstract][Full Text] [Related]
10. Immune response to sublingual immunotherapy in children allergic to mites.
Barberi S; Villa MP; Pajno GB; La Penna F; Barreto M; Cardelli P; Amodeo R; Tabacco F; Caminiti L; Ciprandi G
J Biol Regul Homeost Agents; 2011; 25(4):627-34. PubMed ID: 22217994
[TBL] [Abstract][Full Text] [Related]
11. [The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum].
Xiao C; Li H; Li H; Cheng Z; Qin J; Zhou W; He Q; Xu X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Oct; 24(20):924-7. PubMed ID: 21171297
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
13. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.
Ciprandi G; Cirillo I; Pistorio A; Di Gioacchino M; Fenoglio D
J Biol Regul Homeost Agents; 2009; 23(1):31-6. PubMed ID: 19321044
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
15. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
16. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.
Brimnes J; Kildsgaard J; Jacobi H; Lund K
Clin Exp Allergy; 2007 Apr; 37(4):488-97. PubMed ID: 17430344
[TBL] [Abstract][Full Text] [Related]
19. Quality of life outcomes with sublingual immunotherapy.
Wise SK; Woody J; Koepp S; Schlosser RJ
Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study.
Mauro M; Russello M; Incorvaia C; Gazzola GB; Di Cara G; Frati F
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):119-22. PubMed ID: 17523385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
